Baker / Tisch Capital (GP), LLC Insider Trading $SGEN Seagen Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker / Tisch Capital (GP), LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker / Tisch Capital (GP), LLC. Baker / Tisch Capital (GP), LLC is Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in SEATTLE GENETICS INC /WA ($SGEN) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).

Baker / Tisch Capital (GP), LLC in Seagen Inc.

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker / Tisch Capital (GP), LLC: Director
Holdings: 450,461 shares
Current Value: $27,383,524
Latest Transaction: Jan 04 2012
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Baker / Tisch Capital (GP), LLC in Seagen Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADLR, AUXL, SGEN, GEVA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 04 2012SGENSEATTLE GENETICS I ...Baker / Tisch Capital (GP), LL ...DirectorOption ExerciseX6.2549,563309,7690
Jan 04 2012SGENSEATTLE GENETICS I ...Baker / Tisch Capital (GP), LL ...DirectorBuyX6.2549,563309,769450,461400.9 K to 450.5 K (+12.36 %)

Page:   1